Skip to main content
. 2019 Jan 30;8(2):62–76. doi: 10.1002/psp4.12373

Figure 2.

Figure 2

(a) Effect of quantitative systems pharmacology (QSP) modeling in drug discovery and development, (b) expected near term QSP modeling goals and deliverables, and (c) major obstacles to further progress in QSP modeling. MID3, model‐informed drug discovery and development; MOA, mechanism of action.